We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
4.50 | 0.28% | 1,640.50 | 1,640.00 | 1,640.50 | 1,656.00 | 1,635.00 | 1,642.00 | 5,918,538 | 16:29:57 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.71 | 67.54B |
Date | Subject | Author | Discuss |
---|---|---|---|
15/9/2017 15:07 | Tim3 many thanks. | action | |
15/9/2017 14:51 | Alp, the vaccine is being questioned in terms of effectiveness, again!. I'm taking a view that something is hopefully better than nothing. | essentialinvestor | |
15/9/2017 14:47 | Monty it was north of £15 for starters..but then u weee busy getting your vaccine:) | badtime | |
15/9/2017 14:15 | Essential - take care. "The flu hit Australia harder than it should have this year because the most common strain appears to have mutated since it was formulated into the vaccine, with Britain set to face the same problem". | alphorn | |
15/9/2017 13:56 | Got my flu vaccine booked, with what's happened in Australia not skipping it this year. Expected low 1450's on this type of FX move. | essentialinvestor | |
15/9/2017 13:52 | When as it gone north? lol. Forget about vaccines etc, its all down to traders and a strong pound, thats bad for the dollar earners. 1385p target . | montyhedge | |
15/9/2017 13:10 | And Monty returns when share price heads south ..quiet as a church mouse when it goes north :))))) | badtime | |
15/9/2017 12:37 | The positive opinion on closed triple is helping moderate the decline, somewhat. GSK have high hopes for this. It was odds on to be approved, however to see concrete evidence is good. | essentialinvestor | |
15/9/2017 11:44 | Action If share goes sub £14.60 will be lowest its been for 15 months. | tim 3 | |
15/9/2017 11:27 | Thought there might be an opportunity today we mentioned yesterday, had a small amount, surprised it's not lower. | essentialinvestor | |
15/9/2017 11:11 | The strong pound will kill the FTSE 100 run. | montyhedge | |
15/9/2017 11:06 | I do not understand why this one voing down even after brokers r upgrade | action | |
15/9/2017 11:03 | Tim3 what is 15 month low pls? | action | |
15/9/2017 10:33 | romeike No they are not bonds, but when you know what dividend you will get every year, I can tell you all being well the GSK dividend in two years will be 80p. Its like a bond I said. Ord shares dividends should go up not stay the same for years. NY Boy 1385p. If the pound strengthens. | montyhedge | |
15/9/2017 10:27 | Lol Monty what price you looking for to get back in? | ny boy | |
15/9/2017 10:26 | If 1460 support goes we are looking at 15 month lows,good value imo. | tim 3 | |
15/9/2017 10:12 | Monty - again a totally idiotic statement. You really are special. GSK shares are patently not bonds. | romeike | |
15/9/2017 09:21 | Trouble is this share is really a bond with double the risk, GSK Corporate bond about 4%. Ord share roughly 5% dividend, pays 80p every year, never goes up or down so to me a bond. But could be cut, corporate bond price stays the same and virtually guarantee. | montyhedge | |
15/9/2017 08:38 | Expecting a blue finish today. | marine boy | |
15/9/2017 08:22 | Hoped for lower this m9rning. | essentialinvestor | |
15/9/2017 08:18 | Regulatory applications have been submitted and are undergoing assessment in a number of other countries, including the US, Australia and Canada. FF/UMEC/VI is an investigational medicine not yet approved for use as a single inhaler triple therapy anywhere in the world. The proposed trade name ‘Trelegy Ellipta’ is subject to regulatory approval. | tradermichael | |
15/9/2017 08:17 | Positive newsflow will 0vertake currency exchamge variations: GlaxoSmithKline (LSE:GSK) Intraday Stock Chart Today : Friday 15 September 2017 GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending marketing authorisation for fluticasone furoate/ umeclidinium/vilante | tradermichael | |
15/9/2017 08:04 | 1395p possible if £ continues strong. | montyhedge | |
15/9/2017 08:03 | Sterling of course took dollar earners up, now to take them back down. £ stronger. | montyhedge | |
14/9/2017 19:48 | One thing when I had my shingles vac last week, the doctor said it's a live vaccination, I noticed GSK is not live.I don't know the difference. | montyhedge |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions